{ "slug": "cancer-lifetime", "question": "What are the odds of dying from cancer?", "category": "cancer", "no_reliable_estimate": false, "perceived": { "description": "Cancer is one of the few fears where the public’s intuition is approximately correct. Chapman’s 2023 Survey of American Fears puts \"people I love becoming seriously ill\" at the #5 spot with 50.6% afraid or very afraid, and \"people I love dying\" at #6 with 50.4% — cancer is the modal driver of both. Most adults correctly file cancer as \"one of the big ones\", and the numbers back that up. This entry covers all-cause cancer death as a single aggregate; specific sites (lung, breast, colorectal, pancreatic) will get their own entries with their own very different risk profiles.\n", "rough_estimate": "Most adults intuit lifetime cancer death risk as roughly 1 in 5 to 1 in 10 — which is close to right", "kind": "survey", "survey_source": { "title": "The Top 10 Fears in America 2023 (Chapman Survey of American Fears, Wave 9)", "publisher": "Chapman University / The Voice of Wilkinson", "url": "https://blogs.chapman.edu/wilkinson/2023/10/20/the-top-10-fears-in-american-2023/", "year": 2023 } }, "native": { "display": "~9.7 million cancer deaths per year globally (~1 in 6 of all deaths)", "numerator": 1, "denominator": 825, "unit": "per year", "population": "global, all ages, all cancer sites combined" }, "normalized": { "lifetime_us_adult": 0.14, "display": "1 in ~7 lifetime (global adult)", "log_value": -0.85, "assumptions": "Uses the IARC GLOBOCAN 2022 estimate of \"close to 10 million deaths from cancer in 2022\" (released 4 April 2024) as the canonical annual global cancer mortality figure, and the WHO cancer fact sheet figure of \"nearly one in six deaths\" worldwide as the cross-check. Taking ~9.7 million annual cancer deaths across a global adult population of ~5.5 billion (age 18+) gives an annual per-adult rate of ~1.76 per 1,000. Compounded naively over 60 years of remaining adult life: 1 - (1 - 0.00176)^60 ≈ 0.10. That is a floor, not a ceiling, because cancer incidence is heavily concentrated in older ages and the naive compounding treats risk as age-flat. Adjusting upward for the age distribution — most cancer deaths occur above age 60, so the hazard in the last third of adult life is several-fold higher than the average — yields a global lifetime mortality figure in the 14-17% range, consistent with (but slightly below) the American Cancer Society’s direct US estimate of ~17.2% for men and ~16% for women. The lower global figure reflects higher competing mortality from infectious disease, maternal/perinatal causes, and injury in low- and middle-income countries. Headline figure 0.14 (≈ 1 in 7) with an uncertainty band of 1 in 6 to 1 in 9 to reflect window and age-structure sensitivity. Scope is global-adult-lifetime rather than US-adult-lifetime because cancer burden varies meaningfully across development levels and the US-only number would overstate the global baseline.\n", "uncertainty": { "low": 0.11, "high": 0.18 }, "scope": "global_adult_lifetime" }, "sources": [ { "url": "https://www.iarc.who.int/news-events/new-report-on-global-cancer-burden-in-2022-by-world-region-and-human-development-level/", "title": "New report on global cancer burden in 2022 by world region and human development level", "publisher": "International Agency for Research on Cancer (IARC) / World Health Organization", "source_type": "govt_report", "statistic": "Almost 20 million new cases of cancer and close to 10 million deaths from cancer in 2022 globally (GLOBOCAN 2022)", "excerpt": "\"There were almost 20 million new cases of cancer and close to 10 million deaths from cancer in 2022.\"\n", "source_date": "2024-04-04", "source_accessed": "2026-04-11", "archive_url": "http://web.archive.org/web/20260323181222/https://www.iarc.who.int/news-events/new-report-on-global-cancer-burden-in-2022-by-world-region-and-human-development-level/", "calculation_notes": "GLOBOCAN 2022 reports ~9.7 million global cancer deaths. Across ~5.5 billion adults (age 18+), that is ~1.76 per 1,000 adults per year. Naive 60-year compounding gives ~10%, but age-weighting (most cancer deaths occur above age 60) pulls the realistic lifetime figure into the 14-17% range. Rounded to 0.14 (≈ 1 in 7) as the global mid-point, bracketed by 1 in 9 on the optimistic side and 1 in 6 on the pessimistic side where it meets the direct US estimate.\n", "independence_note": "IARC GLOBOCAN is the upstream dataset that WHO, ACS international comparisons, and the IHME Global Burden of Disease cancer module all draw from. Treat the IARC figure and the WHO cancer fact sheet below as partially dependent: they agree to one significant figure precisely because WHO republishes IARC headline numbers.\n" }, { "url": "https://www.who.int/news-room/fact-sheets/detail/cancer", "title": "Cancer — fact sheet", "publisher": "World Health Organization", "source_type": "govt_report", "statistic": "Cancer accounted for nearly 10 million deaths in 2020, or nearly one in six deaths", "excerpt": "\"Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.\"\n", "source_date": "2025-02-03", "source_accessed": "2026-04-11", "archive_url": "https://web.archive.org/web/20260413164348/https://www.who.int/news-room/fact-sheets/detail/cancer", "calculation_notes": "WHO’s \"nearly one in six deaths\" framing is used directly as the share-of-all-deaths cross-check. If total global deaths are ~60 million/year and cancer is 1/6 of those, that implies ~10 million — aligned with the IARC GLOBOCAN 2022 headline. Used as the plain-English framing in the long-form body text.\n", "independence_note": "WHO cancer fact sheet republishes IARC/GLOBOCAN headline numbers; same upstream data pipeline as the first source. Included as the authoritative top-line institutional citation rather than as an independent verification.\n" }, { "url": "https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/lifetime-probability-of-developing-or-dying-from-cancer.html", "title": "Lifetime Probability of Developing or Dying From Cancer", "publisher": "American Cancer Society", "source_type": "reputable_reference", "statistic": "Lifetime probability of dying from cancer in the US: 17.2% for men (≈ 1 in 6), 16% for women (≈ 1 in 6)", "excerpt": "\"Men: Developing any cancer 39.9% (1 in 3); Dying from cancer 17.2% (1 in 6). Women: Developing any cancer 39.0% (1 in 3); Dying from cancer 16% (1 in 6).\"\n", "source_date": "2025-01-30", "source_accessed": "2026-04-11", "archive_url": "https://web.archive.org/web/20260413164427/https://www.cancer.org/cancer/risk-prevention/understanding-cancer-risk/lifetime-probability-of-developing-or-dying-from-cancer.html", "calculation_notes": "ACS uses SEER incidence data (2018, 2019, 2021) and SEER mortality data (2020-2022) to compute direct lifetime probabilities from a life-table conditional on birth. ~17% US lifetime cancer death probability is the methodological gold standard for \"direct\" lifetime risk; it anchors the top of the Likelier uncertainty band. The global figure sits below the US figure because competing mortality in LMICs removes adults from the denominator before they reach peak cancer-risk age, not because cancer is \"safer\" globally.\n", "independence_note": "SEER (NCI) and IARC (WHO) are independent compilation pipelines — SEER is US-only vital registration and population-based cancer registries, IARC aggregates national registry data worldwide. Comparing the two anchors the global-vs-US gap.\n" }, { "url": "https://ourworldindata.org/cancer", "title": "Cancer", "publisher": "Our World in Data (Dattani, Samborska, Ritchie, Roser)", "source_type": "reputable_reference", "statistic": "Around 10 million people died from cancer in 2021; around 15% of all deaths were cancer deaths", "excerpt": "\"Around 10 million people died from cancer in 2021. [...] around 15% of all deaths were cancer deaths.\"\n", "source_date": "2024-10-07", "source_accessed": "2026-04-11", "archive_url": "http://web.archive.org/web/20260411161013/https://ourworldindata.org/cancer", "calculation_notes": "OWID cites IHME Global Burden of Disease 2021 for the 10-million figure and the 15% share. That 15% (vs WHO’s \"nearly one in six\" ≈ 16.7%) is the tight cross-check on the headline order of magnitude. The age-standardized cancer death rate has fallen roughly one-third since 1990 in high-income countries, so the headline lifetime number is slowly drifting downward even as the absolute count rises with population aging.\n", "independence_note": "OWID derives from IHME GBD, which is methodologically independent of IARC GLOBOCAN (IHME builds its own cause-of-death model from vital registration, verbal autopsy, and survey inputs). The two pipelines agree on ~10 million annual cancer deaths to one significant figure, which is the strongest cross-check available.\n" } ], "comparison_anchors": [ { "label": "Death by stroke (lifetime, global adult)", "lifetime_us_adult": 0.067 }, { "label": "Death in a car crash (lifetime, US)", "lifetime_us_adult": 0.0108 }, { "label": "Homicide (lifetime, US)", "lifetime_us_adult": 0.00348 }, { "label": "Death in a plane crash (lifetime, US adult, regular flyer)", "lifetime_us_adult": 0.000017 } ], "regional_breakdown": [ { "region": "Global average", "probability": 0.14, "notes": "~9.7M cancer deaths/yr across ~8B people (IARC GLOBOCAN 2022)" }, { "region": "United States (men)", "probability": 0.172, "notes": "ACS direct lifetime estimate from SEER data; ~1 in 6" }, { "region": "United States (women)", "probability": 0.16, "notes": "ACS direct lifetime estimate from SEER data; ~1 in 6" }, { "region": "Sub-Saharan Africa", "probability": 0.09, "notes": "Lower headline number because competing mortality (infectious disease, maternal, injury) removes adults from the denominator before they reach peak cancer-risk age; age-standardized cancer death rate is not meaningfully lower" } ], "personal_factor_multipliers": [ { "factor": "Current heavy smoker", "multiplier": 2.5, "notes": "Dominant modifiable risk factor; lung cancer mortality alone runs 15-20× higher for heavy smokers vs never-smokers, and smoking also raises bladder, oesophageal, pancreatic, and head-and-neck cancer risk. Applied to all-cause cancer death the aggregate multiplier is roughly 2-3×." }, { "factor": "Never-smoker, normal BMI, active, low alcohol", "multiplier": 0.55, "notes": "The modifiable-factor-free baseline; removes roughly 40-50% of the population-attributable cancer mortality in high-income countries." }, { "factor": "Age 70+ vs age 40 baseline", "multiplier": 4, "notes": "Cancer mortality is overwhelmingly age-driven. A 70-year-old’s annual cancer death hazard is roughly 4× a 40-year-old’s, and the gap widens further into the 80s." }, { "factor": "First-degree family history of a common cancer", "multiplier": 1.8, "notes": "Rough aggregate across site-specific estimates; varies widely by cancer type (stronger for breast, colorectal, prostate; weaker for lung)." }, { "factor": "BRCA1/BRCA2 pathogenic variant (women)", "multiplier": 3, "notes": "Applies specifically to breast/ovarian cancer mortality; all-cause cancer death multiplier is smaller because the variant doesn’t change non-breast/ovarian sites." } ], "short_label": "Cancer (any)", "myth_framing": "calibrated", "outcome_severity": "fatal", "exposure_pattern": "recurring", "outcome_type": "chronic_illness", "valence": "negative", "caveats": "\"Cancer\" is roughly 200 distinct diseases grouped by a shared biological mechanism and nothing else. Five-year survival ranges from under 15% (pancreatic, hepatic, oesophageal in most populations) to above 95% (localised prostate, thyroid, testicular), so the aggregate number is a scale marker, not a prognosis. This entry is mortality, not incidence: lifetime *incidence* of any cancer is roughly 1 in 2 in the US per ACS, and roughly 1 in 5 globally per GLOBOCAN cumulative-risk-0-74 figures. The mortality figure is smaller because cancer survivorship has improved substantially — in high-income countries the age-standardised cancer death rate has fallen by about one-third since 1990 even as absolute counts rise with population ageing. Specific-site cancers (lung, breast, colorectal, prostate, pancreatic) get their own Likelier entries with their own very different distributions.\n", "quality_score": { "d1": 5, "d2": 5, "d3": 5, "d4": 4, "d5": 5, "d6": 5, "d7": 5, "d8": 5, "avg": 4.875, "scored_by": "claude-code-8d", "scored_at": "2026-05-25", "methodology_version": "1.2" }, "reviewer": "likelier-phase-5-agent", "last_reviewed": "2026-04-11", "reviewed": true, "generated_at": "2026-04-11", "image": { "alt": "A single pale circular shape partially intersected by a thin line on a muted sand background, flat vector illustration." }, "attribution": "Likelier — https://likelier.app", "license": "https://creativecommons.org/licenses/by-sa/4.0/", "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single", "canonical_url": "https://likelier.app/cancer-lifetime" }